Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Tph cells are linked to the severity of systemic lupus erythematosus.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

IL-18 signaling helps mature Tregs move into the thymus.

Treg cells help repair and regenerate tissues by interacting with local cells.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Tislelizumab can cause cutaneous lupus erythematosus.

B cells can both help and hinder the body's defense against melanoma.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Alopecia areata involves specific immune cells, offering potential treatment targets.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Activating TLR3 boosts autophagy gene expression in skin cells.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.